Home / Inspections / 1194474

1194474

Novartis Pharmaceuticals Corporation — FEI 3010353512

Inspection Details

Classification: Voluntary Action Indicated (VAI) (VAI)
End Date: December 9, 2022
Fiscal Year: 2023
Product Type: Biologics
Project Area: Human Cellular, Tissue, and Gene Therapies
Location: Morris Plains, NJ (United States)